January 29, 2024 / 10:06 IST
Reported Standalone quarterly numbers for Astec Lifesciences are:Net Sales at Rs 50.79 crore in December 2023 down 56.65% from Rs. 117.18 crore in December 2022.
Story continues below Advertisement
Quarterly Net Loss at Rs. 24.35 crore in December 2023 down 3040.63% from Rs. 0.83 crore in December 2022.
EBITDA stands negative at Rs. 17.43 crore in December 2023 down 209.55% from Rs. 15.91 crore in December 2022.
Astec Life shares closed at 1,001.35 on January 25, 2024 (NSE) and has given -20.68% returns over the last 6 months and -37.93% over the last 12 months.
| Astec Lifesciences | | Standalone Quarterly Results | in Rs. Cr. |
|
| Dec'23 | Sep'23 | Dec'22 | | Net Sales/Income from operations | 50.79 | 110.79 | 117.18 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 50.79 | 110.79 | 117.18 | | EXPENDITURE | | Consumption of Raw Materials | 43.17 | 72.38 | 111.02 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -7.85 | 3.64 | -41.30 | | Power & Fuel | -- | -- | -- | | Employees Cost | 14.43 | 17.25 | 11.40 | | Depreciation | 8.72 | 9.17 | 8.81 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 19.37 | 20.94 | 23.94 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -27.05 | -12.59 | 3.32 | | Other Income | 0.90 | 0.96 | 3.78 | | P/L Before Int., Excpt. Items & Tax | -26.15 | -11.64 | 7.10 | | Interest | 6.10 | 6.00 | 5.88 | | P/L Before Exceptional Items & Tax | -32.25 | -17.64 | 1.21 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -32.25 | -17.64 | 1.21 | | Tax | -7.90 | -4.19 | 0.39 | | P/L After Tax from Ordinary Activities | -24.35 | -13.45 | 0.83 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -24.35 | -13.45 | 0.83 | | Equity Share Capital | 19.61 | 19.61 | 19.61 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -12.42 | -6.86 | 0.42 | | Diluted EPS | -12.42 | -6.86 | 0.42 | | EPS After Extra Ordinary | | Basic EPS | -12.42 | -6.86 | 0.42 | | Diluted EPS | -12.42 | -6.86 | 0.42 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
